Table 1.
Mild or Moderate Cases, n = 6 (19%) |
Severe Cases, n = 14 (44%) |
Critical Cases, n = 12 (37%) |
p Value | Adjusted p Value | |
---|---|---|---|---|---|
Age in years, median (IQR) | 60 (55–65) | 55 (50–66) | 67 (57–76) | 0.273 | |
Female, n (%) | 5 (83) | 6 (43) | 3 (25) | 0.063 | |
Detection of viremia, n (%) |
2 (33) | 5 (36) | 7 (58) | 0.434 | |
Fatal outcome, n (%) | 1 (17) | 0 (0) | 5 (42) | 0.025 * | |
Leucocytes, median (IQR) | 5.06 (2.79–7.02) | 5.72 (3.82–7.43) | 7.49 (6.71–10.06) | 0.170 | |
Lymphocytes, median (IQR) | 0.9 (0.62–1.44) | 0.89 (0.80–1.37) | 0.78 (0.54–0.89) | 0.461 | |
CRP, median (IQR) | 15 (9–80) | 102 (60–193) | 215 (101–263) | 0.009 * | m/s: 0.076 m/c: 0.010 s/c: 0.076 |
IL-6, median (IQR) | 26 (10–30) | 52 (30–90) | 156 (48–319) | 0.005 * | m/s: 0.035 m/c: 0.015 s/c: 0.035 |
CRP, C-reactive protein; IL-6, interleukin 6; RT-PCR, real-time PCR; IQR, Interquartile range; * p < 0.05.